Autophagy- and MMP-2/9-mediated Reduction and Redistribution of ZO-1 Contribute to Hyperglycemia-increased Blood–Brain Barrier Permeability During Early Reperfusion in Stroke. (1st May 2018)
- Record Type:
- Journal Article
- Title:
- Autophagy- and MMP-2/9-mediated Reduction and Redistribution of ZO-1 Contribute to Hyperglycemia-increased Blood–Brain Barrier Permeability During Early Reperfusion in Stroke. (1st May 2018)
- Main Title:
- Autophagy- and MMP-2/9-mediated Reduction and Redistribution of ZO-1 Contribute to Hyperglycemia-increased Blood–Brain Barrier Permeability During Early Reperfusion in Stroke
- Authors:
- Zhang, Shuai
An, Qier
Wang, Tianfu
Gao, Shuping
Zhou, Guangqian - Abstract:
- Highlights: High glucose causes blood–brain barrier disruption in the early reperfusion of stroke. MMP-2/9-mediated extracellular ZO-1 degradation. Caveolin-1-mediated intracellular translocation of ZO-1. Autophagy-lysosome-mediated ZO-1 degradation. Abstract: Post-stroke hyperglycemia during early reperfusion increases blood–brain barrier (BBB) permeability and subsequently aggravates brain injury and clinical prognosis. The decreased level of tight junction proteins (TJPs) has been reported but the underlying mechanism remains largely elusive. Herein we designed to investigate the detailed molecular events in brain microvascular endothelial cells (BMECs) ex and in vivo . After oxygen–glucose deprivation (OGD) for 90 min and reperfusion with 8 or 16 mM glucose for 30 min, glucose at 16 mM caused significant decrease in the TJP expression and particularly ZO-1 redistribution from membrane to cytoplasm of BMECs. High glucose also markedly promoted the secretion of MMP-2/9 and oxidative/nitrosative stress, enhanced autophagy and increased the Caveolin-1 and LAMP-2 expression. Moreover, in vivo experiments demonstrated that rapamycin-enhanced autophagy further caused ZO-1 reduction and the increased BBB permeability. Therefore, high-glucose exposure in the early reperfusion causes the BBB disruption, with MMP-2/9-mediated extracellular degradation, caveolin-1-mediated intracellular translocation and autophagy-lysosome-mediated degradation of ZO-1 protein all together involvedHighlights: High glucose causes blood–brain barrier disruption in the early reperfusion of stroke. MMP-2/9-mediated extracellular ZO-1 degradation. Caveolin-1-mediated intracellular translocation of ZO-1. Autophagy-lysosome-mediated ZO-1 degradation. Abstract: Post-stroke hyperglycemia during early reperfusion increases blood–brain barrier (BBB) permeability and subsequently aggravates brain injury and clinical prognosis. The decreased level of tight junction proteins (TJPs) has been reported but the underlying mechanism remains largely elusive. Herein we designed to investigate the detailed molecular events in brain microvascular endothelial cells (BMECs) ex and in vivo . After oxygen–glucose deprivation (OGD) for 90 min and reperfusion with 8 or 16 mM glucose for 30 min, glucose at 16 mM caused significant decrease in the TJP expression and particularly ZO-1 redistribution from membrane to cytoplasm of BMECs. High glucose also markedly promoted the secretion of MMP-2/9 and oxidative/nitrosative stress, enhanced autophagy and increased the Caveolin-1 and LAMP-2 expression. Moreover, in vivo experiments demonstrated that rapamycin-enhanced autophagy further caused ZO-1 reduction and the increased BBB permeability. Therefore, high-glucose exposure in the early reperfusion causes the BBB disruption, with MMP-2/9-mediated extracellular degradation, caveolin-1-mediated intracellular translocation and autophagy-lysosome-mediated degradation of ZO-1 protein all together involved in the process. The role of MMP-2/-9 and autophagy in the modulation of paracellular permeability was confirmed by pharmacological inhibition. Therefore, our findings may provide new insights into targeting ZO-1 regulation for the purpose of significantly improving the clinical prognosis of ischemic stroke. … (more)
- Is Part Of:
- Neuroscience. Volume 377(2018)
- Journal:
- Neuroscience
- Issue:
- Volume 377(2018)
- Issue Display:
- Volume 377, Issue 2018 (2018)
- Year:
- 2018
- Volume:
- 377
- Issue:
- 2018
- Issue Sort Value:
- 2018-0377-2018-0000
- Page Start:
- 126
- Page End:
- 137
- Publication Date:
- 2018-05-01
- Subjects:
- 3-MA 3-Methyladenine -- BBB blood–brain barrier -- bFGF basic fibroblast growth factor -- BMECs brain microvascular endothelial cells -- BSA bovine serum albumin -- DMEM Dulbecco's modified Eagle's medium -- FBS Fetal Bovine Serum -- MCAO middle cerebral artery occlusion -- MDCK Madin–Darby canine kidney -- MMPs matrix metalloproteinases -- NOS nitric oxide synthase -- OGD oxygen–glucose deprivation -- TJPs tight junction proteins
hyperglycemia -- stroke -- tight junction proteins -- blood–brain barrier -- autophagy -- ZO-1
Neurochemistry -- Periodicals
Neurophysiology -- Periodicals
Neurology -- Periodicals
Neurochimie -- Périodiques
Neurophysiologie -- Périodiques
Neurochemistry
Neurophysiology
Electronic journals
Periodicals
Electronic journals
612.8 - Journal URLs:
- http://www.sciencedirect.com/science/journal/03064522 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/03064522 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/03064522 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.neuroscience.2018.02.035 ↗
- Languages:
- English
- ISSNs:
- 0306-4522
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6081.559000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 11476.xml